SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from MIRACOR DIAGNOSTICS INC (CIK 0000723906) — Sep 9, 2005

MIRACOR DIAGNOSTICS INC (CIK 0000723906)
Date: Sept. 9, 2005 · CIK: 0000723906 · Accession: 0001019687-05-002563

AI Filing Summary & Sentiment

File numbers found in text: 333-121487

Date
September 9, 2005
Author
Assistant Director
Form
CORRESP
Company
MIRACOR DIAGNOSTICS INC (CIK 0000723906)

Letter

<PAGE> September 9, 2005 Mr. Jeffrey Riedler Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20002

Re: Miracor Diagnostics, Inc. (the Company) Form S-3 Registration Statement File Number: 333-121487

Dear Mr. Riedler;

On behalf of the Company, we hereby request acceleration of the effective date of the Registration Statement under cover of Form S-3 to September 13, 2005 or as soon as practicable thereafter. Please note that in connection with this request for acceleration, we are authorized to represent the following on behalf of the Company:

Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

The Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any additional questions, do not hesitate to contact the undersigned.

DAVID WAGNER & ASSOCIATES, P.C.

/s/ David J. Wagner

David J. Wagner

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>

                                September 9, 2005

Mr. Jeffrey Riedler
Assistant Director
U.S. Securities and
Exchange Commission
100 F Street, N.E.
Washington, D.C. 20002

     Re:  Miracor Diagnostics, Inc. (the Company)
          Form S-3 Registration Statement
          File Number: 333-121487

Dear Mr. Riedler;

     On behalf of the Company, we hereby request acceleration of the effective
date of the Registration Statement under cover of Form S-3 to September 13, 2005
or as soon as practicable thereafter. Please note that in connection with this
request for acceleration, we are authorized to represent the following on behalf
of the Company:

     Should the Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, it does not foreclose the Commission from taking
any action with respect to the filing;

     The action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company from
its full responsibility for the adequacy and accuracy of the disclosure in the
filing; and

     The Company may not assert this action as defense in any proceeding
initiated by the Commission or any person under the federal securities laws of
the United States.

     If you have any additional questions, do not hesitate to contact the
undersigned.

                                     DAVID WAGNER & ASSOCIATES, P.C.

                                     /s/ David J. Wagner

                                     David J. Wagner
</TEXT>
</DOCUMENT>